ArticleTranslational lung cancer research2025

Successful rechallenge of immune checkpoint inhibitors after severe immune-related hepatitis, thyroiditis and hypophysitis in TMB-high NSCLC: a case report.

Zixiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.